WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 4'529  4'495  4'465  4'436  4'404  3'858  3'398  3'147 
Births 60  60  61  61  62  56  58  51 
Surviving infants 60  60  61  61  62  56  57  50 
Pop. less than 5 years 309  312  316  320  319  284  277  256 
Pop. less than 15 years 915  912  910  908  904  878  790  856 
Female 15-49 years 1'064  1'068  1'073  1'078  1'082  992  900  772 

Number of reported cases

(Click for retrospective incidence data for New Zealand)
Diphtheria
ChartChart
  20 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  10  280  68  597  65 
Mumps
ChartChart
  13  18  23  26  52  50 
Pertussis
ChartChart
  1'168  1'099  3'396  5'598  1'992  4'143  91 
Polio*
ChartChart
 
Rubella
ChartChart
  22  26 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for New Zealand)
Vaccine year result method % card seen                                                
BCG          20 
DTP1          93  93  93  94  95  89 
DTP3          92  93  92  93  95  90  90  76 
DTP4          87  84 
IPV1          93  93 
HepB_BD          89 
HepB3          92  93  93  93  95  90 
Hib3          92  93  92  93  94  90 
JapEnc         
MCV1          93  93  92  92  93  85  90  80 
MCV2          87  86  86  85  86 
PCV1          93  93  94  93  94 
PCV3          93  93  93  92  92 
Pol3          92  93  92  93  95  82 
Rota1         
RotaC         
Rubella1          93  93  92  93 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for New Zealand)
DTP1
ChartChart
  93  93  93  94  95  96  96  91 
DTP3
ChartChart
  92  93  92  93  95  90  90  76 
HepB3
ChartChart
  92  93  93  93  95  90 
HepB_BD
ChartChart
 
Hib3
ChartChart
  92  93  92  93  94  90 
MCV1
ChartChart
  93  93  92  92  93  85  90  80 
MCV2
ChartChart
  87  86  86  85  86 
PCV3
ChartChart
  93  93  93  92  92 
Pol3
ChartChart
  92  93  92  93  95  82  90 
RCV1
ChartChart
  93  93  92  92  93  85  90  80 
RotaC
ChartChart
 

Number of districts in the country 20  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 90
From 80 to 89% 10
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes For infants at increased risk of tuberculosis specific individuals as result of TB contact tracing
DTaPHibHepIPV 6 weeks; 3, 5 months; Yes and other eligible individuals
DTaPIPV 4 years; Yes and other eligible individuals
HPV 12 years (x3); Yes
HepA x2 doses Yes specific risk groups
HepB Yes specific risk groups
Hib 15 months; Yes and other eligible individuals
IPV Yes eligible individuals
Influenza_Adult >= 65 years; Yes And adults with chronic diseases, pregnant women, health care workers, Haj and travelers and other risk groups
Influenza_Pediatric Yes At risk children
MMR 15 months; 4 years; Yes and other eligible individuals
MenACWY Yes eligible individuals
MenC_conj Yes Specific risk groups
Pneumo_conj 6 weeks; 3, 5, 15 months; Yes and other eligible individuals
Pneumo_ps Yes high risk children and pre and post splenectomy
Rotavirus 6 weeks; 3, 5 months; Yes
Td 45, 65 years; Yes also for some risk groups
Tdap 11 years; Yes and other eligible individuals
Varicella Yes eligible individuals

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number 20  20  20         

System performance

Total Nº districts in country number 20  20  20  20  20     
Nº districts with DTP3 coverage >=80% number              
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100  100   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.